OncoSil Medical Ltd. announced that it has received notice from Non-Executive Director, Mr. Brian Leedman, that in accordance with clause 13.2 of the Company's constitution regarding the rotation of Directors at each Annual General Meeting (AGM), that he will be retiring from the Company at this year's AGM and will not be standing for re-election.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 AUD | 0.00% | +11.11% | -44.44% |
05-02 | OncoSil Medical Raises AU$5.3 Million under Entitlement Offer | MT |
04-18 | OncoSil Medical Treats Two More Patients in Netherlands in Pancreatic Cancer Trial | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.44% | 10.05M | |
+31.37% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.83% | 239B | |
+9.93% | 211B | |
-6.95% | 203B | |
+10.77% | 171B | |
+0.10% | 163B |
- Stock Market
- Equities
- OSL Stock
- News OncoSil Medical Limited
- OncoSil Medical Limited Announces Retirement of Brian Leedman from the Board